Clinical impact of post‐progression survival on overall survival in patients receiving nivolumab monotherapy as a second‐line treatment for advanced non‐small cell lung cancer

BACKGROUND: The effect of second‐line treatment on overall survival (OS) may be affected by subsequent treatment in patients with non‐small cell lung cancer (NSCLC); however, in such patients, the correlation between post‐progression survival (PPS) and OS is unclear. Our study assessed the correlati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Imai, Hisao, Yamaguchi, Ou, Mori, Keita, Hashimoto, Kosuke, Akagami, Tomoe, Shinomiya, Shun, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Kaira, Kyoichi, Kobayashi, Kunihiko, Kagamu, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046034/
https://ncbi.nlm.nih.gov/pubmed/33626218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13886
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados